Poniard To Present Clinical Data From Picoplatin Trials In Multiple Tumor Types At American Society Of Clinical Oncology 2008 Annual Meeting

Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced that the Company will present data from three clinical trials of picoplatin, in various tumor types and combinations, at poster sessions during the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) at McCormick Place in Chicago.

More: continued here

Filed under: Cancer on May 17th, 2008